Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
J&J prevails in schizophrenia drug patent spat against Teva
11 hours ago
Law
CoRegen closes $93M financing round to enter the clinic and expand its leadership team
12 hours ago
Financing
Manufacturing
Who pays the most in biopharma? We analyzed median pay at 177 companies
15 hours ago
Trump’s CDC nominee Monarez advances to full Senate
16 hours ago
Updated: Merck drops $10B for respiratory drugmaker Verona Pharma in its first acquisition of 2025
18 hours ago
Deals
FDA approves new dosing of Lilly’s Alzheimer’s drug to lower brain swelling risks
19 hours ago
Trump hints at tariff grace period for pharma companies to bring manufacturing to US
Yesterday
Manufacturing
Otsuka’s Taiho reports Phase 3 fail for Duchenne muscular dystrophy drug
Yesterday
In first half of 2025, novel drug approvals are in line with previous years
Yesterday
FDA+
Biopharma's 20 highest-paid CEOs of 2024 with $20M+ paydays
Yesterday
People
Novartis maps launch of malaria drug for newborns after Swiss approval
2 days ago
Clinician groups sue RFK Jr. and HHS over Covid-19 vaccine recommendation changes
2 days ago
R&D
FDA+
Trump's tax cut law expands orphan drug exclusions, could upend 340B program
2 days ago
Law
The Supreme Court passed on a state PBM case. Lawyers say a broader legal fight is brewing
2 days ago
Law
KalVista CEO says FDA review proceeded normally, was unaware of Makary's rejection ask
2 days ago
People
FDA+
Despite delay, KalVista wins FDA approval after Makary's short-lived attempt to intervene
2 days ago
HHS actions to remove web content were arbitrary, 'poorly thought-through,' judge rules
6 days ago
Law
Novartis' Cosentyx fails Phase 3 study for autoimmune disease
6 days ago
R&D
The Trump administration is promoting wearable health devices — with or without evidence
6 days ago
Health Tech
Dizal’s lung cancer pill approval sets up competition with J&J
6 days ago
FDA+
FDA reviewers advised broad label for Moderna’s next-gen Covid vaccine. Prasad overruled them
Last week
FDA+
AbbVie loses bid to block Tennessee's 340B contract pharmacy law
Last week
Law
CDC expands RSV vaccine recommendations, siding with previous panel of agency advisors
Last week
FDA+
After delay, Regeneron wins US approval of bispecific in multiple myeloma
Last week
FDA+
1
2
3
4
Next page
Last page